1560results about How to "Avoid bleeding" patented technology

Methods and systems for endovascular, endocardiac, or endoluminal approaches to a patient's heart to perform surgical procedures that may be performed or used without requiring extracorporeal cardiopulmonary bypass. Furthermore, these procedures can be performed through a relatively small number of small incisions. These procedures may illustratively include heart valve implantation, heart valve repair, resection of a diseased heart valve, replacement of a heart valve, repair of a ventricular aneurysm, repair of an arrhythmia, repair of an aortic dissection, etc. Such minimally invasive procedures are preferably performed transapically (i.e., through the heart muscle at its left or right ventricular apex).

This invention is directed to advanced hemorrhage control wound dressings, and methods of using and producing same. The subject wound dressing is constructed from a non-mammalian material for control of severe bleeding. The wound dressing for controlling severe bleeding is formed of a biomaterial comprising chitosan, a hydrophilic polymer, a polyacrylic polymer or a combination thereof. The kind of severe, life-threatening bleeding contemplated by this invention is typically of the type not capable of being stanched when a conventional gauze wound dressing is applied with conventional pressure to the subject wound. The wound dressing being capable of substantially stanching the flow of the severe life-threatening bleeding from the wound by adhering to the wound site, to seal the wound, to accelerate blood clot formation at the wound site, to reinforce clot formation at the wound site and prevent bleed out from the wound site, and to substantially prohibit the flow of blood out of the wound site.

Devices, systems and methods are disclosed for the formation of an arteriovenous fistula. Embodiments include catheter apparatus including an ablation element for creating and / or modifying the fistula. The devices, systems and methods can be used to treat patients with one or more numerous ailments including chronic obstructive pulmonary disease, congestive heart failure, hypertension, hypotension, respiratory failure, pulmonary arterial hypertension, lung fibrosis and adult respiratory distress syndrome.

This invention is directed to advanced hemorrhage control wound dressings, and methods of using and producing same. The subject wound dressing is constructed from a non-mammalian material for control of severe bleeding. The wound dressing for controlling severe bleeding is formed of a biomaterial comprising chitosan, a hydrophilic polymer, a polyacrylic polymer or a combination thereof. The kind of severe, life-threatening bleeding contemplated by this invention is typically of the type not capable of being stanched when a conventional gauze wound dressing is applied with conventional pressure to the subject wound. The wound dressing being capable of substantially stanching the flow of the severe life-threatening bleeding from the wound by adhering to the wound site, to seal the wound, to accelerate blood clot formation at the wound site, to reinforce clot formation at the wound site and prevent bleed out from the wound site, and to substantially prohibit the flow of blood out of the wound site.

Methods and systems for endovascular, endocardiac, or endoluminal approaches to a patient's heart to perform surgical procedures that may be performed or used without requiring extracorporeal cardiopulmonary bypass. Furthermore, these procedures can be performed through a relatively small number of small incisions. These procedures may illustratively include heart valve implantation, heart valve repair, resection of a diseased heart valve, replacement of a heart valve, repair of a ventricular aneurysm, repair of an arrhythmia, repair of an aortic dissection, etc. Such minimally invasive procedures are preferably performed transapically (i.e., through the heart muscle at its left or right ventricular apex).

A control system for electrosurgical apparatus in which the energy delivery profile of both RF EM radiation and microwave EM radiation delivered to a probe is set based on sampled voltage and current information of RF energy conveyed to the probe and / or sampled forward and reflected power information for the microwave energy conveyed to and from the probe. The energy delivery profile for the RF EM radiation is for tissue cutting (without requiring a sharp blade) and the energy delivery profile for the microwave EM radiation is for haemostasis or sealing or coagulation or ablation of tissue. The RF EM radiation and microwave EM radiation may be applied separately or simultaneously.

In a medical treatment method, magnetic elements are placed into contact with organic tissues of a patient. The magnetic elements are disposed, upon deployment, on opposite sides of tissues or a hole to be closed or collapsed. Owing to magnetic attraction between the magnetic elements, the organic tissues of the patient are held together to constrict tissues or to close or collapse a wound or vessel.

The inventive material is a unique family of externally used wound sealants based upon a binding agent of reactive submicron silica particles that, when hydrated, agglomerate in the form of a supramolecular cross-linked network serving as the structural framework facilitating clot formation. A thrombolytic cascade accelerant can be provided, optionally with additional clotting factors, to further accelerate the clotting process.

This invention is directed to advanced hemorrhage control wound dressings, and methods of using a producing same. The subject wound dressing is constructed from a non-mammalian material for control of severe bleeding. The wound dressing is formed of a biomaterial comprising chitosan for controlling severe bleeding. The kind of severe, life-threatening bleeding contemplated by this invention is typically of the type not capable of being stanched when a conventional gauze wound dressing is applied with conventional pressure to the subject wound. The wound dressing being capable of substantially stanching the flow of the severe life-threatening bleeding from the wound by adhering to the wound site, to seal the wound, to accelerate blood clot formation at the wound site, to reinforce clot information at the wound site and prevent bleed out from the wound site, and to substantially prohibit the flow of blood out of the wound site.

The present invention provides a method for treating an injury of a spinal cord of a patient. The method includes implanting a therapeutic substance in the spinal cord under indirect visualization. The indirect visualization may be provided by an endoscope, and the therapeutic substance may include cells. The present invention also provides a device for treating an injury of the spinal cord. The device includes skin visualization means for visualizing the spinal cord through a skin puncture, and injection means for injecting a therapeutic substance into the spinal cord.

A roofing shingle for enhanced wind / rain durability embodies two transverse lines of adhesion. A first discontinuous line of adhesive joins the butt edge of an overlying shingle to the underlying shingle. Secondly, a band of sealant adjacent the top edge of an underlying shingle seals against an overlying shingle to prevent penetration by wind driven rain to the roof deck. A reduced headlap is thereby permitted, thereby either reducing shingle size or extending shingle coverage. Exposed portions of the sealant band improve the erosion resistance of underlying shingles.

Devices and methods are disclosed for achieving hemostasis in patients who have received skin-penetrating wounds to the body in regions such as the shoulder, pelvis, neck, or groin, where standard bandages are difficult to apply and where large blood vessels exist which can hemorrhage severely. Such haemostatic packing devices and methods are especially useful in the emergency, trauma surgery, or military setting. The devices utilize packing pillows that are held in place by rigid structures that can cause the packing pillows to be brought into the wounds and be held in place while the packing pillows are inflated to fill the wounds, prevent bleeding, and tamponade hemorrhaging large blood vessels exposed therein.

A catheter assembly includes catheter having proximal and distal ends and at least one lumen extending between the ends. At least one end of the catheter is formed from a material that can be trimmed to achieve a selected length for the catheter. A tubular connector is telescoped over the catheter and a hub is joined to the tubular connector. Proximal portions of the hub are configured for connection to a medical apparatus. A cuff is mounted around the tubular connector or the catheter. The cuff is formed from a material that will permit or promote the growth of scar tissue for anchoring the catheter device at least on a semi-permanent basis in a patient.

An aqueous solution of polyacrylic acid is placed in a mold, frozen, and freeze-dried to form a sponge-like polyacrylic acid structure. The sponge-like polyacrylic acid structure is compressed by the application of heat and pressure to reduce the thickness and increase the density of the sponge-like polyacrylic acid structure to form a densified polyacrylic acid structure. The densified polyacrylic acid structure is preconditioned by heating to form a wound dressing. The wound dressing can be applied to control severe, life-threatening bleeding from a wound at a wound site of a person.

An implantable device is provided for controlling hemorrhage in a body cavity, comprising an expandable balloon and a conduit for supplying a physiologically compatible fluid to inflate the balloon. When the balloon tamponade device is implanted or inserted into the body cavity, it is inflated with a physiologically suitable fluid, so that the balloon generally conforms to the body cavity and exerts compressive force against the walls, tissues or structures of the body cavity to control hemorrhage. The balloon may have a deforming means to limit expansion of the balloon in a direction to facilitate expansion of the balloon in another direction. The device may have additional tubes within the conduit, or a plurality of separate lumens within the conduit or tubes to allow drainage and irrigation to the body cavity. There is also provided a cuff for attachment of an external traction to the balloon tamponade, to facilitate the compressive effect of the device. In a preferred embodiment, there is provided a dual balloon tamponade in which two balloons are axially spaced along the conduit, providing a means to control hemorrhage from two distinct body cavities, such as a uterus and a vagina. There is also provided a method to control hemorrhage in a body cavity by implantation or insertion of the balloon tamponade, inflating the balloon with a fluid to a sufficient pressure and retaining the fluid pressure within the balloon for a sufficient period of time to determine whether hemorrhage has been controlled. A kit comprising the balloon tamponade apparatus is also provided.

An apparatus and method for thermally destroying tumors in which heat is generated by electrical resistance heating conducted to the target tissue. Computerized scanning is used to optimize the geometry of a thermal probe. The probe has a metal tip heated by a remote laser. The metal tip is mounted on the end of a wave guide fiber for transmitting the laser radiation to the metal tip. The tip is coated with a thin layer of biocompatible ceramic to avoid coagulated tissue sticking to the tip. The tip has one or more thin, thermally-conductive elements which deploy in stages to coagulate the tumor. The conductive elements may be thin wires or blades. On one embodiment, the conductive elements are composed of a shape memory material that is folded against the tip at lower temperatures and deploys at selected higher temperatures. In another embodiment, the conductive elements are blades that are deployed mechanically. The tip may be provided with a miniature thermocouple to provide temperature feedback information.

The invention relates to a method for preparing composite biological medical material used to avoid adhering organisms, wherein said film is formed by two layers; the layer used as base material is formed by degradable composite macromolecule polylactic acid, glycolic acid, or their copolymer, treated by static spin technique, to make film fiber into nanometer level; then coats one layer of degradable natural macromolecule chitose or relative derivant on the base film, to be treated to obtain the degradable composite biological medical film; and the invention can add different amounts of medical elasticizer between two layers to adjust the degrade speed. The invention can improve immunity with haemostasis function, etc.

An ink set includes at least two aqueous inks A and B with different colors, the inks A and B used in an inkjet recording method in which the inks A and B are superimposed for formation of a color image, wherein the ink A contains water-dispersible colorant A1 free of a surfactant-based dispersant, and anionic compound A2, and wherein the ink B contains water-dispersible colorant B1 containing a surfactant-based dispersant.

The ink set for inkjet recording includes: a first liquid which contains at least a water-soluble solvent, water, and pigment particles dispersed and retained in a medium including the water-soluble solvent and the water; and a second liquid which does not contain coloring material but contains at least a water-soluble solvent, water, and a liquid composition which enhances printing characteristics, wherein: an image is formed by making the first liquid and the second liquid come into contact with each other on a recording medium; and a ratio of pigment particles having a particle diameter of not less than 150 nm is not greater than 2 volume percent with respect to a whole of the pigment particles contained in the first liquid.

Menses regulation and, when desired, contraception is achieved at low doses of estrogen and progestin, which otherwise would create episodes of breakthrough bleeding and / or withdrawal amenorrhea, by periodically inducing menses with an antiprogestin.

The present invention relates to a panel-shaped molded product having a laminated structure which is produced from a resin and used for side doors, back doors, hoods, roofs, etc., and exhibits a more excellent finishing accuracy without occurrence of bleed-out along an inner periphery of a frame part and fine distortions on a design part. The panel-shaped molded product of the present invention is a molded product having a laminated structure which is obtained by injection-molding the frame part (2) on one surface of the plate-shaped design part (1) wherein an inner peripheral portion (4) of the frame part (2) is closely attached to the design part, and has a thickness changing region where a thickness of the frame part is reduced toward the side of a center of the frame part such that a ratio between a width of the thickness changing region and the thickness of the frame part (2), and a ratio between a width of the thickness changing region and a width of the frame part (2) are respectively adjusted to satisfy specific relationships.

A method and a system for using a modular signal device for a room occupancy management system are disclosed here. The method includes the steps of determining the occupancy status of a room associated with the device and generating a signal in the device in response to the determination of the status of the room. The device may be a light bar displaying different color patterns in response to the occupancy status of the room. A room occupancy management system is also disclosed. The system includes a signal device for generating a signal displaying the occupancy status of an associated room and a control unit for controlling the device.

The invention provides a medical anti-sticking membrane and a preparation method thereof. The anti-sticking membrane comprises a nanometer frame and hydrosol attached thereon. The hydrosol is internally packed with one or several kinds of styptic medicament or / and anti-sticking medicament. The invention also provides a preparation method of the anti-sticking membrane, comprising the following steps of: preparing electro-spinning solution, styptic medicament and / or anti-sticking medicament-containing hydrosol solution and crosslinker solution; receiving static spinning with the crosslinker solution to obtain the nanometer frame; printing the styptic medicament and / or anti-sticking medicament-containing hydrosol solution onto the nanometer frame by an ink-jet printer, and solidifying the hydrosol solution to obtain the anti-sticking membrane. The anti-sticking membrane has good capability and biological compatibility, and nontoxicity as well as nonirritant, can be completely degraded and absorbed, is compounded with controllably released styptic medicament or / and anti-sticking medicament, has controllable degrading time and speed, and conquers defects of the prior art.

A flame-retardant resin composition comprises a base resin (e.g., a polyester-series resin), a flame retardant (A) comprising a salt of an amino group-containing triazine compound with a sulfuric acid and / or a sulfonic acid, a flame-retardant auxiliary (B). The flame-retardant auxiliary (B) includes an aromatic resin, acyclic urea-series compound or a derivative thereof [e.g., acetyleneurea, uric acid, a salt of melamine or a condensate thereof (e.g., melam, melem, and melon) with cyanuric acid], an amino group-containing triazine compound (e.g., melamine or a condensate thereof), and / or an inorganic metal-series compound (e.g., a metal salt of an oxygen acid having no sulfur atom, a metal oxide, a metal hydroxide, and a metal sulfide). The present invention provides a flame-retardant resin composition to which flame retardancy is imparted without using a halogen-series flame retardant and an organic phosphorus-series flame retardant.

The invention relates to an anti-cracking low-shrinkage-deformation fiber-cement product and a production method thereof. Concretely, a novel fiber-reinforced cement product with an excellent anti-cracking function and low shrinkage deformation is realized through an ultra-short fiber, low-elasticity-modulus short fiber and high-elasticity-modulus long-fiber composite reinforced-cement base material by simultaneously adopting high-efficiency additives (a high-efficiency water-reducing agent, a thickening agent, an expanding agent and the like). The product comprises a flexible anti-cracking surface layer and a fiber-reinforced cement structural layer, has a simple and resaonable structure, is convenient and easy in production construction and can be applied to projects, such as building external-wall decorative enclosure, indoor engineering construction as well as roads, bridges and the like with higher requirements on the strength and the durability of the cement base material.

Several hemostatic bandages that are commercially available function by tightly sealing a wound so that hemostasis can occur before excessive blood loss takes place. Hemostatic bandages which seal a wound but which do not actually speed the coagulation mechanism include chitosan and chitin-based bandages. Hemostatic gauzes based on chemically modified cellulose are also commercially available. These bandages and gauzes, used in combination with various inorganic materials such as zeolite, silica, and / or diatomaceous earth powder show a synergistic effect. It has been found that the inorganic material activates the contact coagulation mechanism while the biopolymer component binds the wound and prevents excessive blood loss.

An aliphatic polyester stretched film which has excellent flexibility and heat resistance and manifests no bleeding of a plasticizer, an aliphatic polyester composition which is a raw material of the stretched film, and a package using the stretched film. The film can be prepared from an aliphatic polyester composition comprising 10 to 60 parts by weight of at least one compound selected from (A) a compound represented by the general formula: R1OCH2CH(OR2)CH2OR3 (wherein, at least one of R1, R2 and R3 represents an acyl group having 6 to 18 carbon atoms, and remaining groups represent a hydrogen atom or an acetyl group.) and (B) a compound which is a reaction product of a condensate of 1 to 10 glycerin units with a carboxylic acid having 6 to 18 carbon atoms, based on 100 parts by weight of an aliphatic polyester. The aliphatic polyester stretched film can have a crystallinity of 20 to 60% which is obtained by molding the composition, and the film can be formed into a package obtained.